Kate Cwynarski

13PUBLICATIONS
108CO-AUTHORS
Molecular targetsTumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 18, 2026
A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.

|Aug 23, 2026
The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|May 26, 2025
The role of PET/CT in peripheral T-cell lymphoma: Results from the PET/CT substudy of the UK NCRI phase 2 CHEMO-T trial.

M Gleeson, C Gonzalez Arias, D Cunningham

|May 19, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline.

Sridhar Chaganti, Christopher P Fox, Bernard D Maybury

|Nov 11, 2024
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.

Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli

Pageof 3

Frequent Collaborators

6 joint publications

Christopher P Fox

6 joint publications

Pamela McKay

5 joint publications

Toby A Eyre

3 joint publications

Andrew Davies